September 8, 2026
When Digital Health Causes Harm: A Global Review of Real Devices, Apps, and Software That Have Injured or Killed Patients
When Digital Health Causes Harm: A Global Review of Real Devices, Apps, and Software That Have Injured or Killed Patients
The dual pharmacovigilance challenge in rare pediatric diseases: first, medications that can cause rare diseases or rare adverse events; and second, the adverse effects of the medications used to treat these conditions.
The digital revolution—encompassing AI, machine learning, big data analytics, EHRs, mobile applications, and social media monitoring—is reshaping how ADRs are detected, assessed, and prevented.
This essay provides a comprehensive examination of RCA methodologies within, exploring the application of Six Sigma and DMAIC frameworks, the A3 problem-solving approach, and the essential analytical tools including Pareto diagrams, the Five Whys technique, and fishbone (Ishikawa) diagrams.
10 Fundamental patient rights essential for mitigating risks and preventing harm in healthcare settings.
Three persistent myths continue to shape how pharmaceutical companies, biotechs, and even some regulators approach pharmacovigilance (PV), and each one carries a multi-million-dollar price tag.
World Hand Hygiene Day, observed annually on 5 May, has for 18 years championed the single most effective measure to prevent healthcare-associated infections (HAIs): timely and proper hand hygiene.
Advancing Medication Safety Through Knowledge and Vigilance
